The 5′ flank of mouse H19 in an unusual chromatin conformation unidirectionally blocks enhancer–promoter communication  by Kanduri, C. et al.
The 5′ flank of mouse H19 in an unusual chromatin conformation
unidirectionally blocks enhancer–promoter communication
C. Kanduri*, C. Holmgren*, M. Pilartz*†, G. Franklin*, M. Kanduri*, L. Liu*,
V. Ginjala*, E. Ullerås*, R. Mattsson* and R. Ohlsson*
Background: During mouse prenatal development, the neighbouring insulin-like
growth factor II (Igf2) and H19 loci are expressed monoallelically from the
paternal and maternal alleles, respectively. Identical spatiotemporal expression
patterns and enhancer deletion experiments show that the Igf2 and H19 genes
share a common set of enhancers. Deletion of a differentially methylated region
in the 5′ flank of the H19 gene partially relieves the repression of the maternal
Igf2 and paternal H19 alleles in the soma. The mechanisms underlying the
function of the 5′ flank of the H19 gene are, however, unknown.
Results: Chromatin analysis showed that the 5′ flank of the mouse H19 gene
contains maternal-specific, multiple nuclease hypersensitive sites that map to
linker regions between positioned nucleosomes. These features could be
recapitulated in an episomal-based H19 minigene, which was propagated in
human somatic cells. Although the 5′ flank of the H19 promoter has no intrinsic
silencer activity under these conditions, it unidirectionally extinguished
promoter–enhancer communications in a position-dependent manner, without
directly affecting the enhancer function. 
Conclusions: The unmethylated 5′ flank of the H19 gene adopts an unusual
and maternal-specific chromatin conformation in somatic cells and regulates
enhancer–promoter communications, thereby providing an explanation for its
role in manifesting the repressed state of the maternally inherited Igf2 allele.
Background
There is accumulating evidence that regulatory cis ele-
ments separate the genome into large expression domains.
An example is the inactivation, specific for the parent of
origin, of a large cluster of imprinted genes located at the
distal end of the long arm of mouse chromosome 7 [1].
Genetic evidence reveals that at least two members of the
cluster, the H19 and insulin-like growth factor II (Igf2)
genes, which are separated by 90 kb [2], are regulated by
the 5′ flank of the H19 locus [3]. The 5′ flank, which is
methylated in a manner that depends on the parent of
origin [4,5], may serve, therefore, to silence the paternal
H19 and the maternal Igf2 allele, respectively. As the
effects of this deletion mutant show some tissue-specific
variation and are also less pronounced than those obtained
for a larger (13 kb) deletion of this region [6], however, the
possibility that additional imprinting control regions
operate in the vicinity of the H19 locus cannot be excluded. 
The mechanisms underlying the functions of the 5′ flank
of the H19 gene are poorly understood, because it has not
been established whether this region silences the maternal
Igf2 and paternal H19 alleles directly or indirectly, or
whether these processes involve the same or different prin-
ciples. Support for a direct mode of silencing came from
transgenic Drosophila assays which showed that a smaller
region within the differentially methylated domain (DMD)
efficiently repressed expression of reporter genes [7]. A
more straightforward explanation for the silencing of the
paternal H19 allele, however, involves the recruitment of
histone deacetylases to the paternally methylated 5′ flank
via methyl-binding proteins [8,9]. This notion is supported
by the observation that trichostatin A, an inhibitor of
histone deacetylases, derepresses the paternal H19 allele in
the ectoplacental cone during  mouse development
in vitro [10]. A proposed mechanism to explain the silenc-
ing of the maternal Igf2 allele is that a maternal-specific
chromatin insulator prevents the H19 enhancers from com-
municating with the Igf2 promoters [11–14]. This hypothe-
sis of indirect silencing is supported by the observation
that the endodermal H19 enhancers, which are normally
located 3′ of the H19 gene [15], can overcome the repres-
sion of the maternal Igf2 allele if positioned between the
Igf2 and H19 loci [13]. This finding would be explained by
the existence of a chromatin insulator located upstream of
the H19 gene, but downstream of the position of the
exogenous H19 enhancers. A third possibility, which
combines features of both the direct and indirect models
of silencer functions, invokes the idea that the 5′ flank of
the H19 gene has an intrinsic silencer which is flanked by
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insulating chromatin, such that the direction of silencing
switches as a result of female or male germline transmission.
Reasoning that the chromatin conformation holds a key
to the function of the DMD in the 5′ flank of the H19
gene, we devised two convergent approaches: first, to
define parent-of-origin-specific differences in the chro-
matin structure at this region in mouse fetuses; and second,
to examine the function of this domain in transfected
cells under conditions that mimic the maternal-specific
chromatin conformation.
Results
Nuclease hypersensitive sites in 5′ flank of the H19 appear
as doublets and are specific for the maternal allele
Many sites that are hypersensitive to both micrococcal
nuclease (MNase) and DNase I map to the 5′ flank of the
mouse H19 gene when maternally inherited [16,17]. We
extended these data by using reciprocal intraspecific
embryo hybrid crosses. The M. m. musculus allele had a con-
veniently placed BbsI restriction site that was not present in
the M. m. domesticus allele. By digesting the micrococcal
nuclease (MNase)-treated DNA with BclI, BbsI and AflIII,
the M. m. musculus and M. m. domesticus alleles could be
readily separated (Figure 1). Indirect end-labelling with a
short probe (117 bp) showed that the M. m. domesticus
band generated doublets of MNase hypersensitive sites
(NHSSs) at three discrete positions within the putative
silencer region [7], only when it was passaged through the
female germline (Figure 1a and see below). Rehybridisa-
tion of the blot with a longer probe that did not discrimi-
nate the parental origin of the NHSSs, showed that the
degree of MNase digestion was similar for the M × D and
D × M specimens (Figure 1b). Since the same M. m. domes-
ticus allele did not show any NHSS when paternally inher-
ited, these results suggested that the NHSSs were not
intrinsic to the DNA. To exclude the possibility that the
methylation status modified MNase target preferences,
we subjected a purified control and in vitro methylated
BclI–AflIII fragment to MNase digestion. Figure 1c shows
that there was no difference in the pattern of MNase
digestion in the unmethylated control and methylated
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Figure 1
NHSSs within the H19 5′ flank are paired and specific for parent of
origin. (a) MNase-treated nuclei derived from the brain and liver of
intraspecific crosses of M. m. domesticus, D, and M. m. musculus,
M, were digested with AflIII, BclI and BbsI and were subjected to
Southern blot hybridisation analysis with probe 1. Numbers are
fragment sizes in kb. (b) The fetal liver Southern blot of (a) was
rehybridised to probe 2 to verify that the M × D and D × M DNA
samples were similarly degraded by MNase. The arrows show the
MNase hypersensitive sites that are derived from both the
M. m. domesticus (Dom) and M. m. musculus (Mus) alleles in D × M
or M × D crosses. (c) The purified BclI–AflIII fragment was labelled at
its 3′ end and subjected to MNase treatment. The left-hand panel
shows that, although there are some preferred cut sites, these are
not hypersensitive and do not map to the three major NHSSs in (a).
The same result could be obtained by MNase treatment of the
in vitro methylated BclI–AflIII fragment (right-hand panel), excluding
any methylation-specific modification of MNase-preferred cut sites.
(d) A schematic map of the 5′ flank, restriction sites and probes (pr)
is shown. Solid boxes depict H19 exons. Asterisks indicate
polymorphic restriction sites. 
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DNA substrates. Figure 1d shows a schematic map of the 5′
flank. We conclude that the sequences within the DMD,
particularly at the NHSSs in intact chromatin, are poor sub-
strates for the MNase in contrast to the preferred cut sites
at the G-rich region closer to the H19 promoter. The
NHSSs, which could also be observed by use of DNase I
(see Supplementary material), were allele-specific in both
H19-expressing (liver) and non-expressing (brain) tissues
(Figure 1a). The pairs of NHSSs, which presumably flank
short stretches of protein–DNA interactions, do not, there-
fore, seem to be directly associated with gene activity. 
NHSSs map to the linker regions between positioned
nucleosomes within the DMD 
The apparent distribution of the NHSSs in a nucleosome-
like ladder (bands separated by one or two nucleosome-
linker units), implied that the sites mapped to linker
regions between positioned nucleosomes. To examine this
possibility, we treated intact nuclei from fetal liver of
M. m. domesticus conceptuses with MNase, and sequences
within the DMD were indirectly end-labelled with a short
probe (117 bp) in a Southern blot analysis. Figure 2a shows
that more extensive MNase treatment generated an array
of repeated bands spaced one nucleosome-linker unit apart,
on average. This finding suggests that the nucleosomes are
positioned in the DMD and that the NHSSs localise to the
immediate vicinity of some of the linker regions of these
nucleosomes, in both fetal liver and embryonic stem cells
(see Supplementary material), respectively. The idea that
all of the NHSSs actually distributed within the linker
regions was supported by the observation that the sites
were successively degraded by MNase in a manner typical
for nucleosomal linkers. This issue was examined in closer
detail by performing a nucleosomal analysis closer to the
NHSSs. Figure 2b shows that indirect end-labelling of
BglII-digested fetal liver DNA visualised a pair of hyper-
sensitive sites at 0.15 kb and 0.19 kb (representing NHSS
II) upstream of BglII. Since our estimates placed the BglII
site at the nucleosomal-linker boundary of the nucleosome
flanking NHSS II (Figure 3), this finding suggested that
the hypersensitive sites of both NHSS II and III encom-
passed a linker region. There is an additional NHSS region
shown in Figure 2b, which has also been reported by
others [16,17]. We have been unable, however, to docu-
ment this pattern consistently. 
The emergence of repeated band patterns upstream of the
NHSS II site when MNase digestion was increased
(Figure 2b), suggests that the nucleosomes are positioned
over the entire DMD. Given that the NHSSs are maternal-
specific, this nucleosome-like banding pattern should pref-
erentially represent the paternally inherited allele. To
examine whether this region does show positioned nucleo-
somes on one or both parental alleles, the MNase-gener-
ated band patterns were analysed upstream of NHSS I, by
use of reciprocal crosses of intraspecific hybrid mouse con-
ceptuses and a polymorphic BsmAI site, as indicated in
Figure 1d. Figure 2c shows that the nucleosomes are simi-
larly positioned on both alleles. Additional analyses
showed that the nucleosomes are similarly positioned on
both parental alleles over the entire 5′ flank as well as in
the body of the H19 gene (see Supplementary material). 
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Figure 2
MNase hypersensitive sites in the 5′ flank of the H19 gene are located
within linker regions of nucleosomes which are positioned independently
of parent of origin. (a) Indirect end-labelling of BclI–AflIII-digested DNA of
M. m. domesticus fetal liver shows that the nucleosomes in the 5′ flank
are positioned. (b) Indirect end-labelling of BglII-digested DNA shows
that the hypersensitive sites (band sizes 0.67–0.61 kb and 0.19–0.15 kb)
map closely to, or at, the linker region between positioned nucleosomes.
The 0.49–0.44 kb bands are presumably derived from the maternal allele
and flanked by the NHSSs. (c) The nucleosome positioning pattern was
examined for both parental alleles by use of reciprocal intraspecific hybrid
crosses and the BsmAI restriction site polymorphisms. In (a–c) bars
depict the position of nucleosomes and arrows the position of NHSSs.
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Figure 3 summarises the nucleosome positioning and
NHSS data. Several conclusions can be drawn from this
figure. First, both MNase and DNase I NHSSs map to
linker regions between positioned nucleosomes, which are
similarly, if not identically, arranged on both parental
alleles. Second, the NHSSs map at, or in, the immediate
vicinity of a CpG-rich sequence which is repeated several
times in the DMD [18]. Third, the sequence similarity
between the corresponding mouse and human sequences
in the 5′ flank of the H19 gene [18] is restricted to these
repeats, that is only sequences in the linker regions
between positioned nucleosomes in the 5′ flank of the
mouse H19 gene seem to be evolutionarily conserved. 
The maternal-specific chromatin conformation of the 5′
flank of H19 can be generated by default
To examine the possibility that the formation of multiple,
linker-associated NHSSs and positioned nucleosomes occur
within the maternally inherited 5′ flank of the H19 gene by
default, we developed a cell culture assay. This was based
on a 6.5 kb mouse H19 minigene, which included 3.2 kb of
the 5′ flank and 0.8 kb of the 3′ flank; this minigene was
inserted into an episomal (pREP4) vector (see below). The
episomal replication of this vector avoids the position-
dependent chromatin effects that are inherent to stably
integrated plasmids. After transfection of plasmids into
Hep3B cells (long-term transfectants were hygromycin-
selected and propagated for at least 3 months), parameters
of nucleosome positioning and NHSSs were analysed.
Figure 4a,b shows that the nucleosome positioning pattern
of the 5′ flank of the mouse H19 gene of long-term episo-
mally transfected pREPH19 plasmid was indistinguishable
from that of the endogenous (maternally derived) allele in
fetal liver. Moreover, there was no discernible difference in
the position of NHSSs generated by either MNase
(Figure 4b) or DNase I (data not shown) between the long-
term transfected and the in vivo maintained H19 5′ flank.
Similar data could be obtained in JEG-3 cells (of tro-
phoblast lineage) in which the episomal vectors had been
maintained for only 7 days after transfection of the
pREPH19 plasmid (data not shown). Southern and bisul-
phite sequencing analyses showed that the untreated
pREPH19 remained largely unmethylated during the
in vitro culturing conditions (see Supplementary material).
The DMD has no intrinsic silencer activity 
The recapitulation of the unusual chromatin conformation
of the maternally derived 5′ flank of the H19 gene under
defined conditions in human somatic cells enabled us to
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Figure 4
Maternal-specific features of chromatin conformation within the 5′ flank
of the H19 gene can be mimicked in transfected human somatic cells.
After transfection of the pREPH19 vector into Hep3B cells and
propagation for 3–4 months under hygromycin-B selection, nuclei
were isolated and processed as described in Materials and methods.
The pattern of positioned nucleosomes of the H19 5′ flank in H19
minigene-transfected human cells is indistinguishable from that of
mouse fetal liver, as analysed from the (a) AflIII and (b) BglII restriction
sites. The isolated nuclei were treated with MNase for (a) 0, 30, 60,
90, 120 and 150 sec or (b) 0, 30, 60 and 90 sec.
Figure 3
A chromatin map of the 5′ flank of the H19
gene. Maternal-specific NHSSs localise to the
nucleosomal-linker boundaries. The red and
blue rectangles depict estimated nucleosome
positions of maternal-specific and paternal-
specific nucleosomes, respectively. Strong
NHSSs are shown as larger arrows, and
weaker NHSSs as smaller arrows. The pink bar
depicts parent-of-origin-specific differences in
the methylation pattern [4,5] and the vertical
bars identify CpG dinucleotides. The numbers
indicate nucleotide positions relative to the
transcriptional start site of the H19 gene.
Asterisks indicate polymorphic restriction sites. 
bb10h32.qxd  04/17/2000  01:05  Page 452
investigate its function. We first addressed any potential
default silencer activity. If the DMD harbours an intrinsic
silencing activity, the expression of the H19 minigene in
transfected cells should be higher in a vector lacking this
region (to emphasise any such effect, these vectors were not
equipped with any enhancer beyond the minigene context,
see Figure 5a). After transfection and selection for stable
episomal transfectants with hygromycin and maintenance
of pooled clones (about 50 clones) for 3 months, RNase pro-
tection analysis showed that the H19 expression was not
upregulated in pREPH19H-transfected cells in compari-
son with pREPH19-transfected cells (Figure 5b). Southern
blot hybridisation analysis showed that there was no inte-
gration of the plasmid into the genome during the course
of the experiment (data not shown). Because a putative
silencer within the 5′ flank of the H19 gene might operate
only if challenged by an enhancer, we examined whether
this region was able to neutralise the effect of the SV40
enhancer. Figure 5b shows that when the SV40 enhancer
was placed downstream of the H19 gene, it stimulated
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Figure 5
The 5′ flank of the H19 gene has no intrinsic silencer activity but
unidirectionally represses reporter-gene expression in a position-
dependent manner in episomal vectors. (a) Schematic map of the
various constructs used in this study. The maps, which are to scale,
do not show the entire pREP vector. The coloured circle depicts the
position of the SV40 enhancer. All other symbols are explained in the
panel. (b) Absence of default silencer function in the H19 5′ flank.
Episomal vectors were transfected into Hep3B and JEG-3 cells,
which were subsequently propagated for 3 months or 7 days,
respectively. The extracted total cellular RNA was analysed by
RNase protection with (marked with asterisks) or without correction
for episome copy numbers. The right-hand panel of (b) shows
expression of the H19 reporter gene from JEG-3 cells containing an
equal number of episome copies. Hep3B control depicts analysis of
RNA extracted from untransfected Hep3B cells. GAP,
glyceraldehyde-3-phosphate dehydrogenase mRNA. (c) The H19 5′
flank blocks enhancer–promoter interactions. H19 minigene
expression was determined by RNase protection of RNA extracted
from JEG-3 cells which were maintained for 7 days after transfection
with episomal vectors. (d) H19 minigene expression in transfected
JEG-3 cells was quantified with respect to both RNA input and
episome copy number (white bars), as detailed in the Materials and
methods. The grey bars indicate number of hygromycin-selectable
colonies (on average 6.9 × 105 clones per µg pREPH19A), which is
a measure of the SV40 enhancer function. The SV40 enhancer-
driven expression of the pREPH19A construct was, for convenience,
assigned a value of 100 and all other samples were related to this
value. The mean deviation of at least three different experiments is
indicated for each vector construct, unless the differences were too
small to allow visualisation.
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transcription of the mouse H19 reporter gene construct
more than 200-fold in JEG-3 cells, which were maintained
for 7 days after transfection, irrespective of the presence or
absence of the DMD. 
The 5′ flank of H19 unidirectionally blocks
enhancer–promoter communications 
The unusual chromatin conformation at the 5′ flank of the
maternally inherited H19 gene with multiple NHSSs is
similar to the chromatin structure of several chromatin
insulators [14]. The possibility that this region has chro-
matin boundary-like features was examined by use of the
episomal assay system under conditions that allowed the 5′
flank of the H19 gene to adopt the maternal-specific chro-
matin conformations, that is with multiple NHSSs. We ini-
tially assumed that the SV40 enhancer was able to activate
the H19 promoter from both directions in the pREP plas-
mids. The mouse H19 reporter was flanked on either side,
therefore, with the DMD and the endogenous sequences
that separate the DMD and the H19 promoter. If the 5′
flank of the H19 gene operates by regulating enhancer–pro-
moter interactions, the ability of the SV40 enhancer to acti-
vate H19 transcription should be attenuated in a
position-dependent manner. Indeed, the activity of the
SV40 enhancer was virtually extinguished when a second 5′
flank of the H19 gene was inserted between the 3′ end of
the H19 gene and the SV40 enhancer in transfected JEG-3
cells (Figure 5c; quantified in Figure 5d; similar data were
obtained in Hep3B cells, data not shown). The repressing
effect was specific for this region, since a neutral DNA frag-
ment of a similar size did not affect the H19 reporter gene
expression markedly when inserted in the same position
(Figure 5c,d). To rule out the possibility that the presence
of two DMDs squelched the SV40 enhancer activity in a
position-independent manner, we switched the positions
between the 3′ DMD and the SV40 enhancer while
keeping the orientation of the DMD insert with respect to
the SV40 enhancer (pREPH19E, Figure 5a). The SV40
enhancer-directed H19 expression was not significantly
affected by the inclusion of a second 5′ flank, provided that
this was not positioned between the enhancer and the pro-
moter (Figure 5c,d). The notion that the 5′ flank did not
affect the SV40 enhancer directly was further reinforced by
our observation that the SV40 enhancer-potentiated
hygromycin resistance of cells transfected with pREP
vectors was very similar between the pREPH19A and
pREPH19B vectors (Figure 5d, blue bars). 
To examine whether the enhancer-blocking function is
unidirectional, which is a feature of some chromatin insula-
tors [14,19], we reversed the orientation of this region but
kept its position between the SV40 enhancer and H19 pro-
moter. The 5′ flank of the H19 gene was unable to prevent
the SV40 enhancer from activating the H19 promoter
when its orientation was reversed relative to the position
of the enhancer (Figure 5c,d). Given its unidirectional
enhancer-blocking property, the 5′ flank would not be
expected to block the activity of the SV40 enhancer in its
natural position upstream of the H19 promoter within the
episomal vectors. Indeed, deletion of the 5′ flank at this
position showed that the SV40 enhancer activates the H19
promoter only via the 3′ end in the pREP vectors (data not
shown). Taken together, the data strongly suggest that the
5′ flank of the H19 gene blocks enhancer–promoter com-
munications in a unidirectional way without interfering
with the SV40 enhancer function per se.
Discussion
The 5′ flank of the mouse H19 gene is likely to hold a key
to the imprinted regulation of Igf2 and H19 expression,
since its methylation pattern constitutes a gametic mark
specific for the parent of origin, which is propagated in the
soma [4,5], and genetic dissection experiments show that
it is involved in the manifestation or maintenance of the
repressed states of the maternal Igf2 allele and paternal
H19 allele [3]. We show here that an enhancer-blocking
function can be added to this list of H19 5′ flank features.
Our claim is based on the demonstration that the 5′ flank
prevents the strong SV40 enhancer from communicating
with the promoter of the mouse H19 reporter gene only
when it is positioned between the promoter and the
enhancer. This effect, which can be observed under con-
ditions that closely mimic the maternal-specific chromatin
conformation of the 5′ flank, does not depend on any
quenching of the enhancer activity per se, since the SV40
enhancer was fully active in episomal vectors which had
the order of the 5′ flank and the SV40 enhancer reversed.
Our choice of enhancer reflected both the lack of signifi-
cant activity of the endogenous H19 enhancer in our assay
system and our wish to challenge any enhancer-blocking
property with a strong and well-characterised enhancer,
such as the SV40 enhancer.
The unidirectional enhancer-blocking activity of the 5′
flank of the H19 gene is a feature shared with other
enhancer-blocking cis elements, such as the gypsy [14] and
the chicken β-globin insulator [19]. Interestingly, the unidi-
rectional enhancer-blocking activity of the gypsy insulator is
regulated by the mod(mdg4) gene; absence of a functional
mod(mdg4) gene results in bidirectional silencing proper-
ties, suggesting a multicomponent-dependent organisation
of a higher-order chromatin structure [14]. This is poten-
tially analogous to the 5′ flank of the H19 gene, which also
has an unusual chromatin structure with multiple NHSSs
distributed to linker regions between positioned nucleo-
somes. The organisation of positioned nucleosomes does
not require the presence of the NHSSs, since the pater-
nally inherited 5′ flank has a similar nucleosome pattern,
but shows no evidence of any linker-associated NHSSs as
reported here. The reverse may be true, however, since
the interaction of factors to organise a higher-order chro-
matin conformation at the 5′ flank might be facilitated by
454 Current Biology Vol 10 No 8
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positioned nucleosomes, that is the same sequences will be
accessible for factors at any given time by default. Although
it is speculative at this stage, such a feature of the 5′ flank
of the mouse H19 gene could explain the stringency of the
manifestation and maintenance of the repressed state of
the maternal Igf2 promoters during development. 
The basic features of the chromatin conformations in the 5′
flank, as outlined here, are supported by a recent report by
Banerjee et al. [20], but contradict previous conclusions that
the DMD of the 5′ flank is nucleosome-free. Some investi-
gators have argued, for example, that the maternally
derived 5′ flank constitutes a non-nucleosomal template
simply by drawing the analogy with other examples of
NHSS regions that are devoid of nucleosomes [16]. Simi-
larly, the existence of multiple MNase-generated bands
that are too closely spaced to constitute nucleosome-linker
regions has been suggested to reflect a particular chromatin
structure organised by primarily non-histone proteins [17].
Neither of these reports addressed the chromatin conforma-
tion by indirect labelling strategies using very short probes,
that is, probes that do not significantly exceed one nucleo-
some-linker unit in length. Although the NHSSs reported
here and in the study by Khosla et al. [17] are probably the
same, the use of large probes may complicate the analysis of
the nucleosome ladder if there are multiple cuts within the
region covered by the probes. For example, in the report of
Khosla et al. [17], the long probe H19-7 covers the G-repeat
region and its 3′ flank, which are strongly preferred sub-
strates for MNase both in the absence and in the presence
of chromatin structure, as is shown here. As a consequence,
the probability that any extra band in a nucleosomal ladder
might originate from within the H19-7 probe region is sig-
nificant. This issue is further complicated by our observa-
tion that although the nucleosomal positioning pattern is
similar on both parental alleles, it is tissue-specific in the
first exon and promoter sequences, but not in the DMD
(see Supplementary material; data not shown). 
The linker regions of the 5′ flank are clearly interesting
with respect to its chromatin conformation, since the
21 bp repeat (CCGCGT/CGGTGGCAGTC/TA), which
maps at the linker regions at three different positions is
the sole recognisable sequence similarity between the 5′
flanks of the mouse and human H19 genes [18]. In addi-
tion, it is striking that the chromatin conformation of the
maternally inherited 5′ flank of the mouse H19 gene can
also be recapitulated in transgenic Drosophila embryos
(unpublished observations). This observation has a
bearing on the report that the 5′ flank of the H19 gene has
a strong bidirectional silencing activity in transgenic
Drosophila conceptuses [7]. This result is paradoxical at
first glance, since although Drosophila embryos have no
known DNA methylation, it is the unmethylated, mater-
nal H19 allele that escapes silencing in mouse and man.
On the other hand, our observations do not rule out the
possibility that the silencing of the paternal H19 allele
requires a methylation-dependent unmasking of a 5′ flank-
specific silencer activity in mammals. The bidirectional
silencing function in Drosophila could be explained by the
absence of a crucial factor, as exemplified by gypsy and
mod(mdg4). Another possibility, however, is that the nucleo-
some positioning property of the 5′ flank of the H19 gene
has modified the accessibility of crucial reporter-gene-
specific cis elements for regulatory factors and hence is a
side-effect of the default properties of the H19 5′ flank. 
Although we do not yet fully understand the mechanisms
of enhancer action, let alone the function of the enhancer-
blocking cis elements, consideration of the current models
of enhancer action might be helpful. According to the
DNA-looping model, which is supported by experimental
data in some instances, the enhancer-binding factors associ-
ate with the promoter regions or their upstream activator
elements by means of adaptor factors, thereby looping out
intervening sequences [21]. Although the mechanism by
which the chromatin insulators could prevent the formation
of the DNA loop is less obvious (Figure 6a), the linking
model provides a more straightforward explanation in this
regard. This model, which is compatible with all data that
support the DNA looping model, suggests that enhancer
facilitators cover the chromatin fibre to establish communi-
cation between enhancers and target promoters [21]. The
linking model readily explains how enhancer-blocking
functions operate, by simply preventing the extension of
enhancer facilitators, as outlined in Figure 6b. Since our
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Figure 6
Adaptation of the (a) looping and (b) linking models to explain the
enhancer-blocking function of the 5′ flank of the H19 gene. The thin
horizontal black bar indicates the chromatin fibre in the Igf2/H19
domain, and the blue ovals indicate a higher-order chromatin
conformation at the H19 enhancers (pink dots) and 5′ flank (yellow
line), respectively. The enhancer facilitators are depicted as orange
circles. The green and red colours indicate active and inactive loci,
respectively. See [21] for a further discussion of the enhancer models.
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adaptation of this model predicts that the enhancer-block-
ing property is epigenetically regulated, we are currently
addressing the possibility that the methylation status of the
5′ flank controls enhancer–promoter interactions. 
Materials and methods
Mouse strains and tissues 
M. m. musculus (M; CZECH II, Jackson Laboratories) and M. m. domes-
ticus (D; NRMI strain) mice were used to create intraspecific F1 hybrid
conceptuses. These are referred to as D × M or M × D conceptuses con-
sistently, in the order mother-father. Fetuses were collected by natural
matings, taking the date of vaginal plug formation as day 0.5 post-coitum.
Fetal liver and brain were collected at day 16.5 post-coitum. 
Cell culture and transfection 
The JEG-3 and Hep-3B cell lines were maintained in MEM (Gibco-BRL)
as previously described [22,23]. The transfection of plasmid DNAs into
these cells followed previously published protocols [23]. Long-term
transfected Hep3B cells were selected by hygromycin-B [24]. Shorter-
term transfected cells were harvested after 7 days of cell propagation.
MNase/DNase I treatments and Southern blot
hybridisation analysis
Nuclei were isolated as previously described [25]. About 2 × 107 nuclei
were gently resuspended in 2 ml MNase/DNase I digestion buffer
(50 mM Tris–HCl pH 8.0, 5 mM MgCl2, 15 mM NaCl, 0.1 mM CaCl2,
0.1 mM phenylmethylsulfonyl fluoride (PMSF), 0.5 mM DTT and 0.3 M
sucrose) and aliquoted into tubes, washed twice with MNase/DNase I
buffer and treated with 5 units MNase for various times (30 sec, 60 sec,
90 sec and 2 min), in 500 µl reaction volume. The reaction was stopped
by addition of 500 µl stop buffer (10 mM Tris pH 8.0, 10 mM EDTA, 1%
SDS and 400 µg/ml proteinase K). The naked DNA-MNase assay was
performed by digesting a purified BclI/AflIII fragment (both control and
in vitro methylated). Fragments were labelled at the 3′ end by use of
Klenow enzyme and α32P-dCTP as above but in the presence of 5 µg
pREPH19 plasmid and 0.05 units MNase in 150 µl for 30 sec, 60 sec
and 90 sec. For DNase I NHSS assays, nuclei were treated with
increasing amounts of enzyme (10, 20, 40 and 80 units per 500 µl) for
15 min on ice. Reactions were stopped by addition of 500 µl stop
buffer. The digested DNA samples were subjected to electrophoresis in
1.7% agarose gels, depurinated and blotted to Hybond N+ membranes
followed by hybridisation according to routine protocols.
In vitro methylation
Purified fragments (5 µg per experiment) were methylated with
2 units/µg MSssI methyltransferase in the presence of the 180 µM
S-adenosyl methionine for 16 h at 37°C. After termination of methylation
reaction by heating at 65°C for 15 min, the methylation status of purified
fragments was analysed by digesting with on excess of HhaI overnight. 
Probes
Probe 1 was a 117 bp AflIII–Fok1 fragment encompassing sequences
–1253 to –1370 with respect to the cap site; probe 2 was a 637 bp
fragment (generated by PCR amplification with 5′ primer sequence 5′-
TGCAGTACCATAATGCAGACC and 3′ primer sequence 5′-AAGAT-
GACAGTCACCAGCGC-3′) encompassing sequences –2854 to
–3491; probe 3 was a 292 bp fragment (generated by PCR amplifica-
tion with 5′ primer sequence 5′-TTCATAAGGGTCATGGGGTG-3′ and
3′ primer sequence 5′-ATCGGTTATAGGCGGGAGAC-3′ followed by
BglII digestion) encompassing sequences –1987 to –2279; probe 4
was a 336 bp BsmAI–BsmAI fragment encompassing sequences
–3615 to –3951; probe 5 was a 1.05 kb ApaI fragment 5′ of the
PDGFB gene situated between –3678 to –2630 with respect to the
PDGFB cap site; probe 6 was a 2 kb ApaI fragment from pREP4 which
covers the 3′ end of EBNA1 gene and 5′ end of Ori P at positions
7001–8958. All probe fragments were radiolabelled by use of a multi-
prime labelling kit and [α-32P]dCTP (Amersham) to a specific activity of
more than 1 × 108 cpm/µg.
Plasmid cloning strategies
A 6.5 kb mouse H19 minigene (derived from pNOTB, gift of L. Dandolo)
was inserted into the SalI site of the pREP4 vector (Invitrogen), replacing
the RSV LTR and SV40 poly(A) site of the commercial vector. The 5′
end of the minigene insert starts just after a BclI site positioned
3406 bases upstream of the H19 promoter. The removal of part of
the 5′ flank (pREPG/H) was performed by restricting the purified
2.51 kb XbaI fragment with AvrII. The 1.06 kb AvrII–XbaI fragment 3′
of the 5′ flank was subsequently religated into the XbaI-digested
pREPH19 vector. The pREPH19A-D and G plamids were generated
by inserting the 290 bp SV40 enhancer fragment (PCR amplified
from pCAT3 control vector, Promega, with primer sequences that
have ClaI restriction sites: 5′ primer sequence 5′-AAAAATC-
GATAAGCTGATCATCCGCTGTGGAATGTGTG-3′ and 3′ primer
sequence 5′-AAAAATCGATAAGCTGATCCGATAAGGATCTGAACG-3′)
into the unique ClaI site of the pREP plasmids. Since the ClaI site is at
one end of the ampicillin gene in the pREP4 vector, the ampicillin gene
was rescued by incorporating the sequence AGCTGATC (present in
both primers) adjacent to the ClaI site. The pREPH19B, C and F con-
structs were generated by inserting the EcoRI–SalI fragment (which
includes the 5′ flank of the H19 gene) in sense and antisense orienta-
tions, respectively, into the unique SalI site (the upstream SalI site, at
position 8 in pREP4, was mutated by partial digestion of the
pREPH19, endfilling, ligation and screening for intact downstream SalI
site, at position 1092 in pREP4) via intermediate cloning vectors
pCR2.1(Invitrogen) and pBKCMV (Stratagene). The pREPH19E
plasmid was generated by inserting the 290 bp SV40 enhancer frag-
ment into the 3′ SalI site of pREPH19 by T/A cloning strategy. To be
able to insert the 5′ flank of the H19 gene into the unique ClaI site, this
was modified as follows: a multiple cloning site fragment was PCR
amplified from the parent pREP4 plasmid with forward primer 5′-
AAAAATCGATAAGCTGATCTATCATGTCTGGATCCGGCC-3′ and
reverse primer 5′-AAAAATCGATAAGCTGATCCATTCACCACATTG-
GTGTGC-3′ (both primers were flanked with ClaI restriction sites).
This fragment was subsequently inserted into the Cla I site followed by
inserting the 5′ flank into the unique KpnI and XhoI sites of the multiple
cloning site via an intermediate vector (pCR2.1). The construct
pREPH19D was made by inserting a 3.3 kb neutral DNA fragment,
which was derived from a 4.5 kb λ DNA fragment cloned into a Blue-
script plasmid (gift from V. Pirotta), into the 3′ SalI site of pREPH19A.
All the constructs were confirmed by sequencing and were subse-
quently prepared for transfection by propagation in the XL1 Blue strain
of Escherichia coli.
Expression analyses
RNase protection: a 756 bp BamHI–StuI genomic fragment, spanning
exon 3 to exon 5 of mouse H19, was cloned into HincII–BamHI sites of
pBSKS [26]. The plasmid was digested with MscI and transcribed
in vitro using α-32P-UTP (Amersham) and T3 RNA polymerase
(Promega). The resulting full-length antisense transcript encompassed
364 bases, which included 60 bases of plasmid sequences. The pTRI-
GAPDH (glyceraldehyde-3-phosphate dehydrogenase, GAP) plasmid
(Ambion) was digested with DdeI to shorten the protected GAP frag-
ment to 150 bases. 10 µg RNA (including yeast tRNA and various
amounts of total cellular RNA depending on episome copy number) was
hybridised with antisense probes specific for H19 (300,000 cpm per
reaction) and GAP (20,000 cpm/reaction) transcripts, overnight at
45°C. The RNase protection procedure followed the protocols of the kit
manufacturer (Ambion). Quantification of individual protected fragments
was carried out in Fuji Bas 1500 Phosphorimager. The H19 expression
signals were corrected with respect to both internal control (PDGFB
signal) and episome copy number, which was determined by Southern
blot analysis of ApaI-restricted DNA hybridised to probes 5 and 6. 
Supplementary material
Supplementary material including comments on allele-specific chromatin
conformations and figures showing DNase I NHSSs, nucleosome
positioning and methylation status is available at http://current-
biology.com/supmat/supmatin.htm.
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